Related Experiment Videos
Angiogenesis and the fibrinolytic system
G Pintucci1, A Bikfalvi, S Klein
1Department of Cell Biology, New York University Medical Center 10016, USA.
Seminars in Thrombosis and Hemostasis
|January 1, 1996
Summary
This review explores how angiogenic growth factors influence the plasminogen activator/plasmin system, crucial for new blood vessel formation. Understanding these interactions may lead to therapies targeting angiogenesis in diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Physiology
Background:
- Angiogenesis, the formation of new capillaries from existing vessels, is essential for development and wound healing.
- This process requires precise control of endothelial cell behavior and the extracellular matrix.
- The plasminogen activator/plasmin system, a key proteolytic enzyme cascade, plays a critical role in facilitating angiogenesis.
Purpose of the Study:
- To review the role of angiogenic growth factors in modulating the plasminogen activator/plasmin system.
- To elucidate the complex interplay between growth factors, endothelial cell proteolysis, and the extracellular environment.
- To highlight the therapeutic potential of targeting these interactions for disease treatment.
Main Methods:
- Literature review focusing on the molecular mechanisms of angiogenesis.
- Analysis of studies investigating the regulation of the plasminogen activator/plasmin system by growth factors.
- Synthesis of information on the interactions between growth factors, proteases, and the extracellular matrix.
Main Results:
- Angiogenic growth factors significantly influence the expression and activity of the plasminogen activator/plasmin system.
- Specific growth factors promote endothelial cell migration and invasion by activating this proteolytic system.
- The extracellular environment acts as a scaffold and signaling platform, integrating growth factor and protease activities.
Conclusions:
- The intricate relationship between angiogenic growth factors and the plasminogen activator/plasmin system is central to vascular development.
- Targeting this crosstalk offers promising therapeutic strategies for conditions characterized by aberrant angiogenesis.
- Further research into these molecular interactions could unlock novel treatments for angiogenesis-driven pathologies.